We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA: Reauthorize Pediatric Drug Laws, Create Guidance
PhRMA: Reauthorize Pediatric Drug Laws, Create Guidance
May 11, 2011
The drug-industry association Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out in favor of reauthorizing two pieces of legislation designed to encourage research into pediatric therapies, but suggested certain changes to the way pediatric trials are regulated.